The first music video played when MTV debuted was “Video Killed the Radio Star” by The Buggles, which ushered in a new era in the music industry with one technology platform rapidly overtaking another.

Similarly, the Aliri Bioanalysis team recently hosting this webinar to discuss why so many sponsors are now reconsidering the use of Ligand-Binding Assays (LBA) for the vast majority of large molecule protein analysis given the many compelling benefits Liquid Chromatography-Mass Spectrometry (LC-MS) can provide in terms of speed, cost, and data specificity.

Watch this on-deman webinar with bioanalytical experts Shane Karnik, MS, and Matt Hartle, PhD, to learn more about the changing market landscape, pros and cons for each technology, and why you should consider LC-MS over LBA for your next large molecule program.

This webinar will also explores:
• advancements in biomarker discovery, validation and quantification using LC-MS technologies, and
• complexities of analyzing transgenic expressed proteins, focusing on the differences between human and endogenous proteins, with a special emphasis on mRNA drugs.

Join our scientific rock stars to learn more!

Watch on-demand now